2018/06/11

The Association of Copyright for Computer Software (ACCS) warned “game bars” not to infringe the copyright (the screen-presentation right) of game software.
In the “game bars”, which serve food and drink, customers can play home-use game software on big-screen TV.
Some “game bars” will be closed in response to the warning.

Source Yomiuri-Shimbun website(Japanese)
2018/06/07

JPO announced “GUIDE TO LICENSING NEGOTIATIONS INVOLVING STANDARD ESSENTIAL PATENTS”. 

The GUIDE aims to enhance the expectancy of the negotiation involving standard essential patents and reduce the conflict between patent holder and potential licensee.

Following is the English version of the GUIDE.

http://www.meti.go.jp/press/2018/06/20180605003/20180605003-2.pdf

Source Website of the Ministry of Economy, Trade and Industry of Japan
2018/05/31

Following the enactment of the Act on Partial Amendments to the Unfair Competition Prevention Act, etc., grace periods for inventions, utility models and designs will be extended from six months to one year.
The new grace periods will apply to applications filed after June 9, 2018.
Please note that the new grace periods will not apply to inventions, utility models and designs that were disclosed to the public before December 9, 2017.

Source JPO website (Japanese)
2018/05/28

In order to make it easier for venture company to acquire patent in a short period of time, the JPO will ease the requirement for Super accelerated examination in this fiscal year.

Source Yomiuri-Shimbun website (Japanese)
2018/05/21
Yesterday, the 1st stage test for the patent attorney examination was carried out.
The number of candidates was about 4000, and half of them were company employees.
It seems that the number of in-house patent attorneys is increasing (KSI).
Source JPO website (Japanese)
2018/05/11

The Ministry of Economy, Trade and Industry (METI) has compiled a draft of guidelines for contracts on the use of AI and data.

METI is asking for public comment on the draft of the guideline until May 26.

Source Nikkei website (Japanese)
2018/05/10

The Supreme Court did not accept an appeal filed against a grand panel judgment of the IPHC, which judgment had dismissed a claim for an injunction against the manufacture and sale of a generic drug based on a drug-formulation patent right. The grand panel judgement became final and binding.
The issue was the scope of the patent right whose duration was extended.
The following is the grand panel judgement of the IPHC :

www.ip.courts.go.jp/app/files/hanrei_en/136/002136.pdf

Source Nikkei website (Japanese)

TOP